Table 1.
Baseline characteristics of the study group
| Baseline characteristics | |
|---|---|
| Mean age | 52.67 ± 21.08 years |
| Gender distribution | Female: 27 patients Male: 15 patients |
| Mean time-lapse after SVR | 14.6 ± 7.2 months |
| Degree of liver fibrosis | F0-F2: 11 patients F3: 19 patients F4: 12 patients |
| Type of thyroid disease | Autoimmune thyroiditis: 37 patients |
| Hyperthyroidism: 2 patients | |
| Hypothyroidism: 5 patients | |
| ATPO (N <34 IU/mL) |
With autoimmune thyroiditis (37 patients): 982.1 ± 426.6 Without autoimmune thyroiditis (7 patients): 18.4 ± 7.2 |
| antiTG (N< 115 IU/mL) |
With autoimmune thyroiditis (37 patients): 324.2 ± 132.21 Without autoimmune thyroiditis (7 patients): 65.9 ± 21.7 |
| TSH (N: 0.27- 4.2μUI/mL) |
Euthyroidism: 3.87 ± 1.16 Hypothyroidism (under levothyroxine): 2.14 ± 0.81 Hyperthyroidism (under methimazole): 3.27 ± 1.03 |
| fT3 (N: 2.2- 4.4 pg/mL) |
Euthyroidism: 2.11 ± 1.62 Hypothyroidism (under levothyroxine): 3.91 ± 0.62 Hyperthyroidism (under methimazole): 2.57 ± 1.31 |
| fT4 (N: 12- 22 pmol/L) |
Euthyroidism: 15.92 ± 3.53 Hypothyroidism (under levothyroxine): 18.13 ± 6.22 Hyperthyroidism (under methimazole): 16.46 ± 3.13 |
*SVR sustained virologic response after HCV infection.